These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 2103193)

  • 1. [Changes in exercise capacity and in induced ischemia with an oral dose of 5 isosorbide mononitrate in patients with stable angina pectoris].
    Martín Luengo C; Nieto Ballesteros F; Santos Rodríguez I; Diego Domínguez M; Fernández Esteban T; Avila Escribano C; Pavón Osuna P; Cascón Bueno M
    An Med Interna; 1990 Jan; 7(1):24-7. PubMed ID: 2103193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate.
    Bharani A; Ganguli A; Mathur LK; Jamra Y; Raman PG
    Indian Heart J; 2002; 54(2):170-5. PubMed ID: 12086380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of slow-release isosorbide-5-mononitrate on ergometric parameters and cardiac output in stable effort angina pectoris: a double-blind randomized placebo study].
    Romeo F; Barillà F; Pelliccia F; Ferraironi A; Ciolli A; Pannarale G; Vicchio D; Valente A
    Cardiologia; 1989 Jul; 34(7):643-50. PubMed ID: 2676173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.
    Chrysant SG; Glasser SP; Bittar N; Shahidi FE; Danisa K; Ibrahim R; Watts LE; Garutti RJ; Ferraresi R; Casareto R
    Am J Cardiol; 1993 Dec; 72(17):1249-56. PubMed ID: 8256699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia.
    Hennig L; Andresen D; Hennig A; Levenson B; Brüggemann T; Schröder R
    J Clin Pharmacol; 1991 Jul; 31(7):636-40. PubMed ID: 1894759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of isosorbide-5-mononitrate on effort-induced electrocardiographic ischemic changes in patients with angina pectoris.
    Brunner D; Meshulam N; Weisbort J
    Int J Cardiol; 1987 Sep; 16(3):303-7. PubMed ID: 3654028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and chronic effects of once-daily isosorbide-5-mononitrate on the exercise capacity of patients with angina pectoris treated with a beta-blocking drug.
    Eteiba H; Hutton I; Foale RA; Akhras F; Jackson G; Prescott RJ; Hallam RJ; Quinn KJ
    Br J Clin Pract; 1991; 45(3):185-8. PubMed ID: 1687200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and duration of action of isosorbide-5-mononitrate in the treatment of stable angina of effort. Comparison with sustained-release isosorbide dinitrate].
    Lagioia R; Scrutinio D; Mangini SG; De Toma L; Accettura D; De Nicolò M; Saliani P; Preziusi N; Antuofermo F; Rizzon P
    G Ital Cardiol; 1985 Mar; 15(3):299-306. PubMed ID: 4018470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained effect of orally administered isosorbide dinitrate on exercise performance of patients with angina pectoris.
    Markis JE; Gorlin R; Mills RM; Williams RA; Schweitzer P; Ransil BJ
    Am J Cardiol; 1979 Feb; 43(2):265-71. PubMed ID: 367136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isosorbide-5-mononitrate in angina pectoris: plasma concentrations and duration of effects after acute therapy.
    Thadani U; Prasad R; Hamilton SF; Voyles WF; Doyle R; Karpow SA; Reder R; Teague SM
    Clin Pharmacol Ther; 1987 Jul; 42(1):58-65. PubMed ID: 3595067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitrate and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris.
    Seabra-Gomes R; Aleixo AM; Adao M; Machado FP; Mendes M; Bruges G; Palos JL
    Am J Cardiol; 1990 Jun; 65(20):1308-12. PubMed ID: 2188493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
    Parker JO
    Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Isosorbide 5-mononitrate (delayed release) in stable effort angina].
    Almenar Bonet L; Miró Palau V; Gimeno Gascón JV; Algarra Vidal F
    Rev Esp Cardiol; 1992; 45(7):456-61. PubMed ID: 1439070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
    Thadani U
    Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isosorbide-5-mononitrate--effective monotherapy in chronic stable angina.
    Akhras F; Jefferies S; Jackson G
    Z Kardiol; 1985; 74 Suppl 4():16-20. PubMed ID: 3938114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of theophylline and isosorbide dinitrate on exercise capacity in stable angina pectoris, and their mechanisms of action.
    Crea F; Pupita G; Galassi AR; el-Tamimi H; Kaski JC; Davies GJ; Maseri A
    Am J Cardiol; 1989 Nov; 64(18):1098-102. PubMed ID: 2816761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate.
    Thadani U; Maranda CR; Amsterdam E; Spaccavento L; Friedman RG; Chernoff R; Zellner S; Gorwit J; Hinderaker PH
    Ann Intern Med; 1994 Mar; 120(5):353-9. PubMed ID: 8093132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The acute and chronic effects of 50 mg of isosorbide 5-mononitrate with delayed action in patients with stable angina of effort].
    San José Garagarza J; Ruano Calvo J; Vázquez de Prada JA; Colman Dejean T; López Somoza C; Pajarón López A
    Rev Esp Cardiol; 1992 Feb; 45(2):103-10. PubMed ID: 1561466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once- versus twice-daily administration of controlled-release isosorbide-5-mononitrate 60 mg in the treatment of stable angina pectoris. A randomized, double-blind, cross-over study. The Swedish Multicentre Group.
    Nordlander R; Walter M
    Eur Heart J; 1994 Jan; 15(1):108-13. PubMed ID: 8174569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of coronary heart disease with isosorbide mononitrate ('Elantan' 20): a multi-centre study in hospital and general practice.
    Marten W; Weiss M; Haase W
    Curr Med Res Opin; 1984; 9(2):96-106. PubMed ID: 6443349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.